The Evidence Blog

Recent Posts

There Are No Alternative Facts About Evidence-Based Medicine

Posted by The Evidence Blog on March 10, 2017

It’s been quite a week for American healthcare.

The current administration unveiled the first phase of their proposal to “repeal and replace” the Patient Protection and Affordable Care Act (ACA), currently titled the American Health Care Act (AHCA). The reveal has caused no end of concerns for patients, providers, and insurance carriers.

Read More

Evidence: We Set the Gold Standard

Posted by The Evidence Blog on March 1, 2017

We’ve been seeing some talk out there about the “gold standard” when it comes to evidence assessment. Some seem to believe they’re the only ones that provide it. But when it comes right down to it, all that is…is talk.

It’s not just enough to say you use the “gold standard” for evidence assessment. You have to define it. You have to live it. You have to embody it.

 Hayes does.

Read More

Topics: Hayes Blog, Healthcare Evidence, Health Technology Assessments,

3 Questions with Dr. Nierman of Tufts Health Plan

Posted by The Evidence Blog on February 27, 2017

This week, we were fortunate enough to have a conversation with Dr. Nierman of Tufts Health Plan, located in Watertown, MA. The Tufts Health Plan is a nonprofit organization, founded in 1979, that is nationally recognized for its commitment to providing innovative, high-quality healthcare coverage. The plan offers members and employers an array of health management programs, which support evidence-based approaches to health and wellness. Dr. Nierman has served as the Medical Director for Medical Policy for more than 18 years, and took the time to speak with us regarding why the plan made the decision to subscribe to Hayes for our unbiased evidence evaluations to better serve their health plan members.

Read More

Topics: Health Technologies, Payers, Hayes Blog, Health Technology Assessments,

Analytical Validity, Clinical Validity, and Clinical Utility: What’s the Difference?

Posted by The Evidence Blog on February 7, 2017

Genetic testing is seemingly everywhere today. No longer are discussions of tumor profiling, gene panels, genomics and proteomics confined to the scientific realm. Major news outlets cover new advances in genetic testing, as well as some of the hidden risks associated with their exponential growth in the consumer market (See our blog Evidence Shines a Light on the Hidden Dangers of Genetic Testing). Technical innovations, such as next-generation sequencing, have accelerated the development of such tests. Consequently, there is increasing demand on you as both physicians and payers to provide your patients and clients with the best possible test solutions. But how do you decide? There are three essential criteria to consider when making your determinations regarding genetic testing.

Read More

Topics: Payers, Hospitals, Hayes Blog, Healthcare Evidence, Genetic Testing

Phil Is Flawed: Groundhog Day’s Startling Lack of Evidence

Posted by The Evidence Blog on February 2, 2017

We at Hayes are on the lookout for bad science, no matter what the setting. Every year, we sat quietly on the sidelines while throngs of admirers gathered at Gobbler’s Knob to witness the ever popular Punxsutawney Phil’s powers of prognostication.

But we decided, in the name of evidence and the scientific method, that we would remain silent no more. We reached out to Phil’s representatives in an attempt to discern the methodology he employs to make such bold and confident predictions about winter weather patterns. What we found out might surprise you. Excerpts from the conversation follow below.

Read More

Topics: Hayes Blog

NPR Piece: “Research-Quality” Data Crucial to EHR-Guided Treatment

Posted by The Evidence Blog on January 17, 2017

Like it or not, electronic medical/health records (EMR/EHR) are here to stay. As the healthcare world continues to move away from fee-for-service and toward value-based medicine, there is an increasing need to accumulate historical data regarding patient outcomes in order to individualize patient management, treatment, and develop best practices. But as innovative health systems develop and implement programs to take advantage of the reams of data available to them, it becomes clear that there are crucial elements that must be considered.

Read More

Topics: Hospitals, Hayes Blog, Genetic Testing, Consumers

Neptune Waste Management System Back in Operating Suites

Posted by The Evidence Blog on January 3, 2017

The Neptune Waste Management Systems are used in operating room (OR) suites and surgical facilities to collect and dispose of surgical fluid waste. Some models also remove smoke generated at surgical sites by electrocautery or laser devices. In 2012, the manufacturer of these systems issued a voluntary class I recall. The Food and Drug Administration (FDA) defines class I recalls as those issued in situations in which there is a reasonable probability that the use of or exposure to a product will cause serious adverse health consequences or death.

Read More

Topics: Health Technologies, Hospitals, Hayes Blog, Devices, recalls

Getting to Know Hayes – Shannon Brode, MPH; Product Manager, Health Technology Briefs, Evidence Solutions

Posted by The Evidence Blog on November 22, 2016

Whether you’re a current or prospective client of Hayes, we feel it is important for you to know our team. Throughout the year, we’ll introduce you to another valuable contributor to the Hayes mission of providing fiercely-unbiased evidence. Meet Shannon Brode.

Read More

Topics: Hayes Blog

It’s FDA Approved! But is it Ready for My Coverage Policy?

Posted by The Evidence Blog on June 22, 2016

The Hayes Client Symposium is just about 3 months away and we’re busy preparing our accredited sessions for our health plan clients who will be in attendance. I’m personally excited to be part of the session focusing on the FDA approval process and the impact this has on coverage policy. This is always a hot topic for our health plan clients.

Some background about the FDA:
The Food and Drug Administration (FDA) can trace its origins as a federal consumer protection agency to the passage of the 1906 Pure Food and Drugs Act. The 1906 Act was passed in response to public outrage at the startlingly unsanitary conditions in the Chicago meatpacking industry described by Upton Sinclair in his landmark book, The Jungle.

Read More

Ameda or Medela: Which breast pump is better?

Posted by The Evidence Blog on May 5, 2016

In the last decade, there have been multiple revelations about the health benefits of breastfeeding. Babies that are breastfed exclusively in the first 6 months are less susceptible to ear infections and respiratory problems, and to developing allergies. As a result, the United States has experienced a 25% increase in nursing mothers since the mid-1990s. Even the IRS is weighing in on the issue; breastfeeding has been proven to be so beneficial, mothers get tax breaks for breast pumps.

Read More

Topics: Hayes Blog

Sign up to receive updates from our blog

Our latest articles

New Call-to-action